Profile data is unavailable for this security.
About the company
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
- Revenue in ILS (TTM)59.95bn
- Net income in ILS-2.11bn
- Incorporated1944
- Employees35.00k
- LocationTeva- Pharmaceutical Industries Ltd.124 Dvora Hanevi'a StTEL AVIV-YAFO 6944020IsraelISR
- Phone+972 39148213
- Fax+972 39234050
- Websitehttps://www.tevapharm.com/
More ▼
20.91%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (Global Investors)as of 01 Apr 2023 | 114.79m | 10.24% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 41.03m | 3.66% |
| The Vanguard Group, Inc.as of 29 Feb 2024 | 35.88m | 3.20% |
| KSM Mutual Funds Ltd.as of 31 Jan 2024 | 12.46m | 1.11% |
| Meitav Mutual Funds Ltd.as of 31 Jan 2024 | 10.80m | 0.96% |
| Migdal Mutual Funds Ltd.as of 31 Jan 2024 | 5.46m | 0.49% |
| Harel Mutual Funds Ltd.as of 31 Jan 2024 | 4.59m | 0.41% |
| Psagot Mutual Funds Ltd.as of 31 Jan 2024 | 4.19m | 0.37% |
| DWS Investments (UK) Ltd.as of 04 Apr 2024 | 2.76m | 0.25% |
| Charles Schwab Investment Management, Inc.as of 04 Apr 2024 | 2.46m | 0.22% |
More ▼
Data from 31 Dec 2023 - 31 Jan 2024Source: FactSet Research Systems Inc.
